Treatment of end-stage dilated cardiomyopathy with growth hormone;Die therapie der terminalen dilatativen kardiomyopathie mit wachstumshormon

Zeitschrift fur Kardiologie

Volumn 87, Issue 6, 1998, Pages 425-435

  Dreifuss, P ^a  

^a NONE   (Switzerland)

Author keywords

Chronic congestive heart failure; End stage dilated cardiomyopathy; Recombinant human growth hormone

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HUMAN GROWTH HORMONE; NITRATE; SOMATOMEDIN BINDING PROTEIN 1;

ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; COST EFFECTIVENESS ANALYSIS; DRUG EFFECT; HEART DILATATION; HEART FUNCTION; HEART PERFORMANCE; HUMAN; NONHUMAN; PHASE 2 CLINICAL TRIAL; RISK BENEFIT ANALYSIS;

ADULT; ANIMALS; CARDIOMYOPATHY, DILATED; CARDIOVASCULAR AGENTS; CLINICAL TRIALS, PHASE II; COMBINED MODALITY THERAPY; GROWTH HORMONE; HEART FAILURE, CONGESTIVE; HEMODYNAMIC PROCESSES; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MYOCARDIAL CONTRACTION; VENTRICULAR FUNCTION, LEFT;

EID: 0031858155     PISSN: 03005860     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003920050197     Document Type: Article

References (41)

1. Ambler R, Johnston B, Maxwell L, Gavin J, Gluckman P (1993) Improvement of doxorubicin induced cardiomyopathy in rats treated with insulin-like growth factor I. Cardiovasc Res 27:1368-1373
2. Anand I, Ferrari R, Kalra G, Wahi P, Poole-Wilson P, Harris P (1989) Edema of cardiac origin: studies on body water and sodium, renal function, haemodynamic indexes, and plasma hormones in untreated congestive heart failure. Circulation 80: 299-305
3. Anker S, Chua T, Ponikowski P, Harrington D, Swan J, Kox W, Poole-Wilson P, Coats A (1997) Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation 96:526-534
4. Antoni H (1983) Funktion des Herzens. In: Schmidt R, Thews G (Hrsg) Physiologie des Menschen. Springer Verlag, Berlin, S 391-433
5. Beer N, Tortoledo F, Beer R, Pinedo M, Fermin E (1997) Beneficial effets of growth hormone in patients with chagas cardiomyopathy and dilated cardiomyopathy of unknown etiology. Circulation 96 (Suppl 1):I-521, Abstract 2920
6. Broglio F, Gianotti L, Fubini A, Morello M, Gallina A, Arvat E, Deghenghi R, Ghigo E (1997) Activity of GH/IGF-1 axis in patients with dilated cardiomyopathy. Annales d'Endocrinologie 58 (Suppl 1):88 (Poster P1-12)
7. Cittadini A, Grossman J, Napoli R, Katz S, Strömer H, Smith R, Clark R, Morgan J, Douglas P (1997) Growth hormone attenuates early left ventricular remodeling and improves cardiac function in rats with large myocardial infarction. J Am Coll Cardiol 29:1109-1116
8. Copeland K, Nair K (1994) Recombinant human insulin-like growth factor-1 increases forearm blood flow. J Clin Endocrinol Metab 79:230-232
9. Corpas E, Harman S, Blackman M (1993) Human growth hormone and human aging. Endocr Rev 14:20-39
10. Courville C, Mason V (1938) The heart in acromegaly. Arch Intern Med 61:704-713
11. Donath M, Jenni R, Brunner H, Anrig M, Kohli S, Glatz Y, Froesch E (1996) Cardiovascular and metabolic effects of insulin-like growth factor 1 at rest and during exercise in humans. J Clin Endocrinol Metab 81:4089-4094
12. Dreifuss P (1997) Growth hormone in cardiovascular medicine. Cardiovasc Res, im Druck (per 18. 11. 1997 zur Publikation angenommen)
13. Dreifuss P (1997) Growth hormone in chronic heart failure. Circulation, im Druck (per 21. 09. 1997 zur Publikation angenommen)
14. Dreifuss P (1997) Growth hormone in end-stage heart failure. Lancet 349:1841-1842
15. Dreifuss P (1996) Wachstumshormon - ein pathogenetischer Faktor bei chronisch-kongestiver Herzinsuffizienz? Dtsch Med Wochenschr 121:492-496
16. Dreifuss P (1996) Wachstumshormon - ein pathogenetischer Faktor bei chronisch-kongestiver Herzinsuffizienz? Dtsch Med Wochenschr 121:1279
17. Duerr R, Huang S, Miraliakbar H, Clark R, Chien K, Ross J (1995) Insulin-like growth factor-I enhances ventricular hypertrophy and function during onset of experimental cardiac failure. J Clin Invest 95:619-627
18. Duerr R, McKirnan M, Gim R, Clark R, Chien K, Ross J (1996) Cardiovascular effects of insulin-like growth factor-1 and growth hormone in chronic left ventricular failure in the rat. Circulation 93:2188-2196
19. Farrell T, Jepson N, Evans T, Lipkin D, Bouloux P (1995) Growth hormone abnormalities in severe heart failure. Br Heart J 73 (Suppl):P13 (Poster 26)
20. Fazio S, Sabatini D, Capaldo B, Vigorito C, Giordano A, Guida R, Pardo F, Biondi B, Saccà L (1996) A preliminary study of growth hormone in the treatment of dilated cardiomyopathy. N Engl J Med 334: 809-814
21. Frustaci A, Gentiloni N, Russo M (1996) Growth hormone in the treatment of dilated cardiomyopathy. N Engl J Med 335: 672-673
22. Frustaci A, Perrone G, Gentiloni N, Russo M (1992) Reversible dilated cardiomyopathy due to growth hormone deficiency. Am J Clin Pathol 97:503-511
23. Guistina A, Lorusso R, Borghetti V, Bugari G, Misitano V, Alfieri O (1996) Impaired spontaneous growth hormone secretion in patients with severe dilated cardiomyopathy. Am Heart J 131:620-622
24. Hofbauer L, Heufelder A (1996) Wachstumshormon - ein pathogenetischer Faktor bei chronisch-kongestiver Herzinsuffizienz? Dtsch Med Wochenschr 121:1074
25. Hosenpud J, Bennett L, Keck B, Fiol B, Novick R (1997) The registry of the International Society for Heart and Lung Transplantation: fourteenth official report -1997. J Heart Lung Transplant 16:691-712
26. Jin H, Yang R, Gillett N, Clark R, Ko A, Paoni N (1995) Beneficial effects of growth hormone and insulin-like growth factor-1 in experimental heart failure in rats treated with chronic ACE inhibition. J Cardiovasc Pharmacol 26:420-425
27. Mercado M, Davilla N, McLeod J, Baumann G (1994) Distribution of growth hormone receptor messenger ribonucleic acid containing and lacking exon 3 in human tissues. J Clin Endocrinol Metab 78: 731-735
28. Mertani H, Delehaye-Zervas M, Martini J, Postel-Vinay M, Morel G (1995) Localization of growth hormone receptor messenger RNA in human tissues. Endocrine 3: 135-142
29. O'Driscoll J, Green D, Ireland M, Kerr D, Larbalestier R (1997) Treatment of end-stage cardiac failure with growth hormone. Lancet 349:1068
30. Osterziel K, Strohm O, Schuler J, Friedrich M, Bohlender J, Ranke M, Dietz R (1997) Influence of therapy with recombinant human growth hormone on left ventricular mass and function in dilated cardiomyopathy. Circulation 96 (Suppl 1):I-712. Abstract 3992
31. Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies (1995) Br Heart J 44:672-673
32. Rosen T, Bengtsson B (1990) Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 336:285-288
33. Rudman D, Feller A, Nagraj H, Gregans G, Lalitha P, Goldberg A, Schlenker R, Cohn L, Rudman I, Mattson D (1990) Effects of human growth hormone in men over 60 years old. N Engl J Med 323:1-6
34. Russell-Jones D, Bates A, Umpleby A, Hennessy T, Bowes S, Hopkins K, Jackson N, Kelly J, Shojaee-Moradie F, Jones R, Soenksen P (1995) A comparison of the effects of IGF-1 and insulin on glucose metabolism, fat metabolism and the cardiovascular system in normal human volunteers. Eur J Clin Invest 25:403-411
35. Ryoke T, Hongo M, Mao L, Clark R, Ross J (1997) Recombinant human growth hormone improves ventricular performance in late stage hamster cardiomyopathy. Circulation 96 (Suppl 1):I-521, Abstract 2921
36. Strasburger C, Schopohl J, Kann P, Oertel H (1997) Diagnostische Kriterien für die Indikation zur Wachstumshormon-Substitution bei Erwachsenen. Dtsch Med Wochenschr 122:861-863
37. Thuesen L, Christiansen J, Soerensen K, Joergensen J, Orskov H, Henningsen P (1988) Increased myocardial contractility following growth hormone administration in normal man. An echocardiographic study. Dan Med Bull 35:193-196
38. Toyozaki T, Hiroe M, Hasumi M, Horie T, Hosoda S, Tsushima T, Sekiguchi M (1993) Insulin-like growth factor-1 receptors in human cardiac myocytes and their relation to myocardial hypertrophy. Jpn Circ J 57: 1120-1127
39. Volterrani M, Desenzani P, Lorusso R, d'Aloia A, Manelli F, Guistina A (1997) Haemodynamic effects of intravenous growth hormone in congestive heart failure. Lancet 349:1067-1068
40. Wright A, Hill D, Lowy C, Fraser T (1970) Mortality in acromegaly. Q J Med 39:1-16
41. Yang R, Bunting S, Gillett N, Clark R, Jin H (1995) Growth hormone improves cardiac performance in experimental heart failure. Circulation 92:262-267